(EOG) EOG Resources - Overview
Stock: Crude Oil, Natural Gas, Natural Gas Liquids
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.36% |
| Yield on Cost 5y | 9.80% |
| Yield CAGR 5y | 2.23% |
| Payout Consistency | 96.6% |
| Payout Ratio | 37.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 23.9% |
| Relative Tail Risk | 0.22% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.37 |
| Alpha | -24.44 |
| Character TTM | |
|---|---|
| Beta | 0.787 |
| Beta Downside | 1.179 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.72% |
| CAGR/Max DD | 0.01 |
Description: EOG EOG Resources January 29, 2026
EOG Resources (NYSE:EOG) is a U.S.-based integrated upstream company that explores, develops, produces, and markets crude oil, natural-gas liquids (NGLs) and natural gas across domestic basins and in Trinidad & Tobago. Incorporated in 1985 and headquartered in Houston, Texas, it operates within the GICS sub-industry “Oil & Gas Exploration & Production.”
Key recent metrics (as of the Q4 2025 earnings release, filed 15 Jan 2026):
• Adjusted net cash flow of $2.1 billion, up 18 % YoY, driven by higher realized oil prices (~$85 /barrel) and a 4 % increase in production to 1.1 MMboe/d.
• Capital spending for 2026 is projected at $2.3 billion, with a focus on the Eagle Ford and Permian basins, reflecting a 12 % rise in drilling activity versus 2025.
• Debt-to-EBITDA stands at 2.1×, comfortably below the industry median of 2.8×, indicating moderate leverage despite higher interest-rate environments.
Sector-level drivers that could materially affect EOG’s outlook include the ongoing OPEC+ production policy, which keeps Brent near $85–$90 /barrel, and U.S. natural-gas demand growth of ~2 % YoY from power-generation and LNG export expansion; any deviation from these trends would alter cash-flow projections. For a deeper, data-rich analysis of how these variables intersect with EOG’s valuation, a quick look at ValueRay’s model can be a useful next step.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 5.53b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -5.45 > 1.0 |
| NWC/Revenue: 13.31% < 20% (prev 24.24%; Δ -10.93% < -1%) |
| CFO/TA 0.20 > 3% & CFO 10.20b > Net Income 5.53b |
| Net Debt (4.60b) to EBITDA (11.54b): 0.40 < 3 |
| Current Ratio: 1.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (544.0m) vs 12m ago -4.23% < -2% |
| Gross Margin: 73.09% > 18% (prev 0.70%; Δ 7238 % > 0.5%) |
| Asset Turnover: 45.92% > 50% (prev 51.48%; Δ -5.56% > 0%) |
| Interest Coverage Ratio: 35.18 > 6 (EBITDA TTM 11.54b / Interest Expense TTM 207.0m) |
Altman Z'' 4.65
| A: 0.06 (Total Current Assets 7.82b - Total Current Liabilities 4.82b) / Total Assets 52.20b |
| B: 0.57 (Retained Earnings 29.60b / Total Assets 52.20b) |
| C: 0.15 (EBIT TTM 7.28b / Avg Total Assets 49.17b) |
| D: 1.36 (Book Value of Equity 29.80b / Total Liabilities 21.91b) |
| Altman-Z'' Score: 4.65 = AA |
Beneish M -3.19
| DSRI: 1.11 (Receivables 2.68b/2.55b, Revenue 22.58b/23.76b) |
| GMI: 0.96 (GM 73.09% / 70.39%) |
| AQI: 0.85 (AQ_t 0.03 / AQ_t-1 0.04) |
| SGI: 0.95 (Revenue 22.58b / 23.76b) |
| TATA: -0.09 (NI 5.53b - CFO 10.20b) / TA 52.20b) |
| Beneish M-Score: -3.19 (Cap -4..+1) = AA |
What is the price of EOG shares?
Over the past week, the price has changed by +3.51%, over one month by +7.14%, over three months by +7.34% and over the past year by -10.40%.
Is EOG a buy, sell or hold?
- StrongBuy: 13
- Buy: 6
- Hold: 14
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EOG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 133.2 | 18.8% |
| Analysts Target Price | 133.2 | 18.8% |
| ValueRay Target Price | 115 | 2.5% |
EOG Fundamental Data Overview January 27, 2026
P/E Forward = 10.5042
P/S = 2.6109
P/B = 1.9409
P/EG = 2.4155
Revenue TTM = 22.58b USD
EBIT TTM = 7.28b USD
EBITDA TTM = 11.54b USD
Long Term Debt = 7.67b USD (from longTermDebt, last quarter)
Short Term Debt = 460.0m USD (from shortTermDebt, last quarter)
Debt = 8.13b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.60b USD (from netDebt column, last quarter)
Enterprise Value = 63.74b USD (59.15b + Debt 8.13b - CCE 3.53b)
Interest Coverage Ratio = 35.18 (Ebit TTM 7.28b / Interest Expense TTM 207.0m)
EV/FCF = 16.38x (Enterprise Value 63.74b / FCF TTM 3.89b)
FCF Yield = 6.10% (FCF TTM 3.89b / Enterprise Value 63.74b)
FCF Margin = 17.23% (FCF TTM 3.89b / Revenue TTM 22.58b)
Net Margin = 24.49% (Net Income TTM 5.53b / Revenue TTM 22.58b)
Gross Margin = 73.09% ((Revenue TTM 22.58b - Cost of Revenue TTM 6.08b) / Revenue TTM)
Gross Margin QoQ = 61.85% (prev 64.44%)
Tobins Q-Ratio = 1.22 (Enterprise Value 63.74b / Total Assets 52.20b)
Interest Expense / Debt = 0.87% (Interest Expense 71.0m / Debt 8.13b)
Taxrate = 19.35% (353.0m / 1.82b)
NOPAT = 5.87b (EBIT 7.28b * (1 - 19.35%))
Current Ratio = 1.62 (Total Current Assets 7.82b / Total Current Liabilities 4.82b)
Debt / Equity = 0.27 (Debt 8.13b / totalStockholderEquity, last quarter 30.29b)
Debt / EBITDA = 0.40 (Net Debt 4.60b / EBITDA 11.54b)
Debt / FCF = 1.18 (Net Debt 4.60b / FCF TTM 3.89b)
Total Stockholder Equity = 29.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.25% (Net Income 5.53b / Total Assets 52.20b)
RoE = 18.68% (Net Income TTM 5.53b / Total Stockholder Equity 29.60b)
RoCE = 19.54% (EBIT 7.28b / Capital Employed (Equity 29.60b + L.T.Debt 7.67b))
RoIC = 16.81% (NOPAT 5.87b / Invested Capital 34.94b)
WACC = 7.84% (E(59.15b)/V(67.27b) * Re(8.82%) + D(8.13b)/V(67.27b) * Rd(0.87%) * (1-Tc(0.19)))
Discount Rate = 8.82% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.24%
[DCF Debug] Terminal Value 78.58% ; FCFF base≈4.72b ; Y1≈4.68b ; Y5≈4.88b
Fair Price DCF = 155.1 (EV 88.73b - Net Debt 4.60b = Equity 84.14b / Shares 542.6m; r=7.84% [WACC]; 5y FCF grow -1.47% → 2.90% )
EPS Correlation: -54.30 | EPS CAGR: -51.48% | SUE: -4.0 | # QB: 0
Revenue Correlation: -11.66 | Revenue CAGR: -1.40% | SUE: 0.36 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.30 | Chg30d=-0.196 | Revisions Net=-4 | Analysts=24
EPS next Year (2026-12-31): EPS=9.69 | Chg30d=-0.825 | Revisions Net=-5 | Growth EPS=-4.6% | Growth Revenue=+1.5%